Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Strikingly, exendin-4 was stable against DPP-4 [16,17]
E-values were calculated to quantify robustness to unmeasured confounding
GLP-1 receptor agonists also reduce the three components of MACE, including CV mortality (reduced by 13%), nonfatal stroke (reduced by 16%) and nonfatal myocardial infarction (reduced by 9%, although the level of significance was not reached)
Backed by landmark clinical trials and prescribed by physicians worldwide for chronic weight management
US$ 29.14
US$ 26.42
US$ 22.88
